Pembrolizumab: Rapidly moving the field forward through industry-academic collaborations

Date 10 October 2016
Event ESMO 2016 Congress
Session Transforming academia-industry partnerships to expedite clinical development of innovative anti-cancer agents
Topics Immunotherapy
Therapy
Presenter Paul Haluska
Authors P. Haluska
  • Global Center For Scientific Affairs, Merck, 07065 - Rahway/US